scispace - formally typeset
J

Jane E.B. Reusch

Researcher at Anschutz Medical Campus

Publications -  205
Citations -  14552

Jane E.B. Reusch is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 52, co-authored 177 publications receiving 13023 citations. Previous affiliations of Jane E.B. Reusch include United States Department of Veterans Affairs & Durham University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.

TL;DR: Data indicate that regulation of Bcl-2 expression by IGF-I involves a signaling cascade mediated by PI 3-kinase/PDK1/Akt/CREB, and the observation that enhanced CREB activity by Akt signaling leads to increased B cl-2 promoter activity and cell survival.
Journal ArticleDOI

CREB Activation Induces Adipogenesis in 3T3-L1 Cells

TL;DR: The data firmly establish CREB as a primary regulator of adipogenesis and suggest that CREB may play similar roles in other cells and tissues.
Journal ArticleDOI

Diabetes and Advanced Glycoxidation End-Products

TL;DR: The incidence of diabetes, especially type 2 diabetes, is increasing at an alarming rate assuming epidemic proportions (1). Worldwide, 124 million people had diabetes by 1997, although an estimated 221 million people will have diabetes by the year 2010.
Journal ArticleDOI

Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function

TL;DR: The phenotype of IR in T1D youth was unique, suggesting a pathophysiology that is different from T2D, yet may adversely affect long-term cardiovascular outcomes, and impaired functional exercise capacity and cardiovascular dysfunction.